Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Claude Opus commit added malicious npm dependency in Feb 2026, enabling crypto theft and persistent RAT access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results